Key points are not available for this paper at this time.
To face the challenges posed by the scale-up of nanomedicines, practical experimental designs could provide efficient solutions.Once scale-up is achieved, nanomedicines will be made better available in the market for the treatment of a myriad of diseases."
Muthu et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: